Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1992-11-17
1995-04-11
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
A61K 4900
Patent
active
054055970
ABSTRACT:
The invention relates to radiolabeled imaging of a mammalian body. The invention in particular provides for reagents labeled with technetium-99m for such imaging. The invention specifically provides somatostatin, somatostatin derivatives, somatostatin analogues or peptides that bind to the somatostatin receptor and contain at least 2 cysteine residues that form a disulfide or wherein the disulfide is reduced to the sulfhydryl form that are labeled with technetium-99m and that can be targeted to specific sites within a mammalian body for imaging.
REFERENCES:
patent: 4434151 (1984-02-01), Byrne et al.
patent: 4444690 (1984-04-01), Fritzberg
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4485101 (1984-11-01), Coy et al.
patent: 4571430 (1986-02-01), Byrne et al.
patent: 4575556 (1986-03-01), Byrne et al.
patent: 4853371 (1989-08-01), Coy et al.
patent: 4861869 (1989-08-01), Nicolotti et al.
patent: 4871717 (1989-10-01), Coy et al.
patent: 4877868 (1989-10-01), Reno et al.
patent: 4904642 (1990-02-01), Coy et al.
patent: 5078985 (1992-01-01), Rhodes
patent: 5096696 (1992-03-01), Galanakis
patent: 5116596 (1992-05-01), Bremer et al.
patent: 5128119 (1992-07-01), Griffiths
patent: 5177192 (1993-01-01), Pak et al.
patent: 5196510 (1993-03-01), Rodwell et al.
patent: 5225180 (1993-07-01), Dean et al.
Cox, P. H. et al., European Journal of Nuclear Medicine, vol. 18, No. 8, p. 558, Aug. 1991.
Sundrehagen, Int. J. Appl. Radiat. Isot., vol 34, No. 7, pp. 1003-1007, 1983.
Rhodes, Sem. Necl. Med. 4: 281-293 (1974).
Davison et al., Inorg. Chem. 20: 1629-1632 (1981).
Fritzberg et al., J. Nucl. Med. 23: 592-598 (1982).
Khaw et al., J. Nucl. Med. 23: 1011-1019 (1982).
Bryne and Tolman, J. Nucl. Med. 24: P126 (1983).
Bryson et al., Inorg. Chem. 27: 2154-2161 (1988).
Bakker et al., J. Nucl. Med. 31: 1501-1509 (1990).
Bryson et al., Inorg. Chem. 29: 2948-2951 (1990).
Kwekkeboom et al., J. Nucl. Med. 32: 981 (1991).
Bakker et al., J. Nucl. Med. 32: 1184-1189 (1991).
Larson, J. Nucl. Med. 32: 1189-1191 (1991).
Albert et al., Abstract LM10, 12th American Peptide Symposium: 1991.
Cox et al., Abstract, 7th International Symposium on Radiopharmacology, (1991).
Fischman et al., "A Ticket to Ride: Peptide Radiopharmaceuticals," J. Nuc. Med. 34 (12), Dec. 1993, pp. 2253-2263.
Buttram Scott
Dean Richard T.
Lister-James John
Chapman Lara E.
Diatech Inc.
Stoll Robert L.
LandOfFree
Technetium-99m labeled somatostatin-derived peptides for imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Technetium-99m labeled somatostatin-derived peptides for imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Technetium-99m labeled somatostatin-derived peptides for imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536814